International Journal of Clinical Oncology

Papers
(The H4-Index of International Journal of Clinical Oncology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers99
Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106)95
What has changed in malignant mesothelioma between 1990 and 2019? A time- series analyses in Turkey62
Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations43
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy41
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib34
Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution33
The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma31
Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review29
Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study28
Treatment outcome of laparoscopic surgery after self-expandable metallic stent insertion for obstructive colorectal cancer26
Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy25
Long-term results of fluorescence and indigo carmine blue dye-navigated sentinel lymph node biopsy25
The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study24
Estimated tumor blood flow as a predictive imaging indicator of therapeutic response in pancreatic ductal adenocarcinoma: use of three-phase contrast-enhanced computed tomography23
Comparison of therapeutic features and oncologic outcome in patients with pN1 prostate cancer among robot-assisted, laparoscopic, or open radical prostatectomy23
Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy23
Risk factors of mFOLFOX6-induced hyperammonemia in patients with colorectal cancer: an observational study22
Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery21
Availability of genome-matched therapy based on clinical practice21
Trends in the surgical treatment for metastatic spinal tumor in Japanese administrative data between 2012 and 202020
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy20
Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer20
0.13153100013733